Pozen Inc. (POZN) – Bull of the Day
Source: http://www.zacks.com/commentary/10146/Pozen+Inc.+%28POZN%29+-+Bull+of+the+DayPosted on Thursday, February 26th, 2009 | In Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -
Pozen Inc. (POZN) is one of our top-picks for small-cap biotech. We see the fundamentals as strong and the valuation as absurdly low.
Treximet trends are improving and sales should start to dramatically improve in the coming months. Plus, with the FDA recently confirming the primary endpoint in the phase III PN clinical trials, Pozen and partner AstraZeneca should be in position to file for approval of PN by the middle of the year.
Phase III plans for PA are also moving forward and should begin by the third quarter. We see both products as $500 million opportunities. By 2013, we think Pozen can deliver revenues close to $200 million, with net income well above $100 million.
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- 3 Turkeys to Short Right Now - Investment Ideas - November 26th, 2009
- VIP Falls Behind Expectations - Analyst Blog - November 25th, 2009
- J. Crew Beats Zacks Estimates - Analyst Blog - November 25th, 2009
- No Change in Deere's Outlook - Analyst Blog - November 25th, 2009
- Sprint Acquires Virgin Mobile USA - Analyst Blog - November 25th, 2009
Tags for this Post:
Astrazeneca, Day Pozen Inc.;, Fda, PA;, Pozen Inc., Stocks to Watch, USD, Zacks Market Commentaries
Astrazeneca, Day Pozen Inc.;, Fda, PA;, Pozen Inc., Stocks to Watch, USD, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.